# Central Pennsylvania Blood Bank Headquarters – FDA Inspection, Mar 13, 2014

Source: https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank-headquarters/501e5d02-46ef-45fa-8ef6-d981fee5c91a
Source feed: FDA_Inspections

> FDA inspection 869762 of Central Pennsylvania Blood Bank Headquarters, March 13, 2014. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 869762
- Company Name: Central Pennsylvania Blood Bank Headquarters
- Inspection Date: 2014-03-13
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1222397 - 2023-10-19
- FDA Inspection 1179906 - 2022-09-01
- FDA Inspection 1068986 - 2018-08-14
- FDA Inspection 961421 - 2016-02-26
- FDA Inspection 773412 - 2012-03-22

Company: https://www.keypedia.com/companies/central-pennsylvania-blood-bank-headquarters/38fcc2fb-766a-4032-a720-565cf3e3b20e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d